-
EC eCQMs - Eligible Clinicians
-
Resolution: Answered
-
Moderate
-
None
-
None
-
Andrew Kurecki
-
(828) 231-0676
-
Allergy Partners
-
-
CMS0156v12
-
The recommended guidelines published for the use of Hydroxyzine and Amitriptyline on patients with Neuropathic itch and cough appear to impact scores for this inverse measure.
Regarding quality measure CMS156v11Use of High-Risk Medications in Older Adults; I am inquiring if all providers that are following the recommended guidelines for treating neuropathic itch and/or cough with Amitriptyline or Hydroxyzine; will they be penalized for using these meds to treat these conditions?